Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

No man is an island as they say... and as OTC CEOs

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 155579
(Total Views: 1080)
Posted On: 07/20/2020 12:18:07 PM
Posted By: DJknows
Re: reallypeople? #43936
No man is an island as they say... and as OTC CEOs they are often at the mercy, if you will, of others coming through... so yes it takes time.

I've only known of CytoDyn since Dec. as I started researching due to my Mom's fatal cancer diagnosis (died from bone cancer in less than two months from diagnosis) and March 26th when I first started investing at .95 pps (have averaged up ... a lot, since... in my first OTC biotech I might add).

One may say I lucked out with my timing, but I can say I lucked out with CYDY but how many others have I NOT lucked out with/in... we all have stories.

What is fortunate for CytoDyn is UNFORTUNATELY Covid-19 came along... so yes, maybe everything is moving faster now for Leronlimab ...

The history of CytoDyn / Leronlimab is so fascinating to me ... I've read and posted some history like this which is worthy of repeating:

http://www.allendallen.com/Memorium-Allen-D-Allen.html

Now in this last interview with Dr. Been Saturday, the newer history to be as stated by Dr. Pourhassan:

Dr. Paul Madden founded Leronlimab (Pro140) 25 years ago

Dr. Denis Burger (brought on Board Feb. 2014) patented Leronlimab for cancer

Dr. Scott Kelly stays updated on the cancer science and Leronlimab checks off the boxes

Dr. Bruce Patterson finds Leronlimab can deal with ARDS which is at the heart of Covid-19

Dr. Nader Pourhassan early on wants to keep shareholders in the loop ... to know Leronlimab is the potential savior for Covid-19 patients

And the magnificent and extraordinary story continues.... while Leronlimab history is being made... "miracle" "homerun" "gem" "lifesaver"




































(8)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us